Liminal Biosciences
Belleville, CA · 2 known investors
Find your way into Liminal Biosciences
Sign up to see every warm intro you have to Liminal Biosciences
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Liminal Biosciences team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Liminal BioSciences, through subsidiary CALEDON BIOSCIENCE, discovers and develops small molecule therapeutics targeting G protein-coupled receptor pathways for metabolic, inflammatory, and fibrotic diseases. The company applies drug discovery and medicinal chemistry expertise to create novel therapeutic candidates in underexplored GPCR pathways.
Founders & leadership
B
BruceChief Executive Officer
Investors · 2
Founder mafia
2 people who came through Liminal Biosciences went on to found or lead other companies.
Frequently asked questions
- What does Liminal Biosciences do?
- Liminal BioSciences, through subsidiary CALEDON BIOSCIENCE, discovers and develops small molecule therapeutics targeting G protein-coupled receptor pathways for metabolic, inflammatory, and fibrotic diseases. The company applies drug discovery and medicinal chemistry expertise to create novel therapeutic candidates in underexplored GPCR pathways.
- Who are Liminal Biosciences's investors?
- Liminal Biosciences's investors include AmorChem, Western Technology Investment.
- Where is Liminal Biosciences headquartered?
- Liminal Biosciences is headquartered in Belleville, CA.



